CRMD – CorMedix Inc.
CRMD — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
22.38
Margin Of Safety %
42
Put/Call OI Ratio
0.67
EPS Next Q Diff
-0.33
EPS Last/This Y
-1.44
EPS This/Next Y
-0.07
Price
7.17
Target Price
14.57
Analyst Recom
1
Performance Q
-41.18
Upside
259.0%
Beta
1.49
Ticker: CRMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | CRMD | 6.57 | 0.63 | 1.43 | 76342 |
| 2026-03-10 | CRMD | 6.72 | 0.62 | 0.53 | 75823 |
| 2026-03-11 | CRMD | 6.68 | 0.62 | 0.01 | 76593 |
| 2026-03-12 | CRMD | 6.41 | 0.62 | 0.20 | 76594 |
| 2026-03-13 | CRMD | 6.4 | 0.62 | 0.20 | 76594 |
| 2026-03-17 | CRMD | 6.47 | 0.60 | 0.04 | 76678 |
| 2026-03-18 | CRMD | 6.38 | 0.60 | 0.56 | 77048 |
| 2026-03-19 | CRMD | 6.3 | 0.59 | 0.80 | 77231 |
| 2026-03-20 | CRMD | 6.28 | 0.57 | 0.54 | 76484 |
| 2026-03-23 | CRMD | 6.43 | 0.83 | 0.05 | 55820 |
| 2026-03-24 | CRMD | 6.47 | 0.77 | 0.26 | 58723 |
| 2026-03-25 | CRMD | 6.62 | 0.76 | 0.15 | 58714 |
| 2026-03-26 | CRMD | 6.71 | 0.75 | 0.05 | 59329 |
| 2026-03-27 | CRMD | 6.72 | 0.70 | 0.16 | 61659 |
| 2026-03-30 | CRMD | 6.57 | 0.69 | 0.24 | 62491 |
| 2026-03-31 | CRMD | 6.79 | 0.69 | 0.03 | 62758 |
| 2026-04-01 | CRMD | 7.02 | 0.68 | 0.21 | 62894 |
| 2026-04-02 | CRMD | 7.05 | 0.67 | 0.07 | 64292 |
| 2026-04-06 | CRMD | 7.08 | 0.67 | 0.32 | 64676 |
| 2026-04-07 | CRMD | 7.16 | 0.67 | 0.21 | 64904 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | CRMD | 6.57 | 133.3 | - | 1.04 |
| 2026-03-10 | CRMD | 6.73 | 133.3 | - | 1.04 |
| 2026-03-11 | CRMD | 6.68 | 133.3 | - | 1.04 |
| 2026-03-12 | CRMD | 6.40 | 133.3 | - | 1.04 |
| 2026-03-13 | CRMD | 6.45 | 10.0 | - | 0.81 |
| 2026-03-17 | CRMD | 6.46 | 10.0 | - | 0.81 |
| 2026-03-18 | CRMD | 6.37 | 10.0 | - | 0.81 |
| 2026-03-19 | CRMD | 6.30 | 10.0 | - | 0.81 |
| 2026-03-20 | CRMD | 6.28 | 10.0 | - | 0.81 |
| 2026-03-23 | CRMD | 6.43 | 10.0 | - | 0.81 |
| 2026-03-24 | CRMD | 6.47 | 10.0 | - | 0.81 |
| 2026-03-25 | CRMD | 6.62 | 10.0 | - | 0.81 |
| 2026-03-26 | CRMD | 6.72 | 10.0 | - | 0.81 |
| 2026-03-27 | CRMD | 6.72 | 10.0 | - | 0.81 |
| 2026-03-30 | CRMD | 6.58 | 10.0 | - | 0.81 |
| 2026-03-31 | CRMD | 6.80 | 10.0 | - | 0.81 |
| 2026-04-01 | CRMD | 7.02 | 10.0 | - | 0.81 |
| 2026-04-02 | CRMD | 7.05 | 10.0 | - | 0.81 |
| 2026-04-06 | CRMD | 7.07 | 10.0 | - | 0.81 |
| 2026-04-07 | CRMD | 7.17 | 10.0 | - | 0.81 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | CRMD | -4.36 | -7.99 | 23.87 |
| 2026-03-10 | CRMD | -4.36 | -7.99 | 23.87 |
| 2026-03-11 | CRMD | -4.36 | -7.99 | 23.47 |
| 2026-03-12 | CRMD | -3.19 | -7.99 | 23.47 |
| 2026-03-13 | CRMD | -2.62 | -7.99 | 23.47 |
| 2026-03-17 | CRMD | -2.50 | -7.96 | 23.47 |
| 2026-03-18 | CRMD | -2.50 | -7.96 | 23.47 |
| 2026-03-19 | CRMD | -2.50 | -7.96 | 23.47 |
| 2026-03-20 | CRMD | -2.50 | -7.96 | 23.47 |
| 2026-03-23 | CRMD | -2.50 | -7.92 | 23.47 |
| 2026-03-24 | CRMD | -2.50 | -7.92 | 23.47 |
| 2026-03-25 | CRMD | -2.50 | -7.92 | 22.38 |
| 2026-03-26 | CRMD | -2.50 | -7.92 | 22.38 |
| 2026-03-27 | CRMD | -2.50 | -7.92 | 22.38 |
| 2026-03-30 | CRMD | -2.50 | -7.91 | 22.38 |
| 2026-03-31 | CRMD | -2.50 | -7.91 | 22.38 |
| 2026-04-01 | CRMD | -2.50 | -7.91 | 22.38 |
| 2026-04-02 | CRMD | -2.50 | -7.91 | 22.38 |
| 2026-04-06 | CRMD | -2.50 | -7.23 | 22.38 |
| 2026-04-07 | CRMD | -2.50 | -7.23 | 22.38 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.61
Avg. EPS Est. Current Quarter
0.33
Avg. EPS Est. Next Quarter
0.28
Insider Transactions
-2.5
Institutional Transactions
-7.23
Beta
1.49
Average Sales Estimate Current Quarter
104
Average Sales Estimate Next Quarter
95
Fair Value
10.15
Quality Score
99
Growth Score
53
Sentiment Score
44
Actual DrawDown %
58.9
Max Drawdown 5-Year %
-72.9
Target Price
14.57
P/E
3.61
Forward P/E
13.71
PEG
P/S
1.82
P/B
1.4
P/Free Cash Flow
3.28
EPS
1.98
Average EPS Est. Cur. Y
0.81
EPS Next Y. (Est.)
0.73
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
52.31
Relative Volume
0.37
Return on Equity vs Sector %
12.5
Return on Equity vs Industry %
29.1
EPS 1 7Days Diff
-0.5
EPS 1 30Days Diff
-0.46
EBIT Estimation
◆
CRMD
Healthcare
$7.17
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
59.2
Range 1M
100%
Sup Dist
2.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-61.5%
EPS NY
-33.5%
52W%
9.3%
Long-Term Value
Quality companies, undervalued
WATCH
🟢 BUY
+49.3% upside
Upside
+49.3%
Quality
99
MoS
42%
CorMedix Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 191
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
CRMD
Latest News
—
Caricamento notizie per CRMD…
stock quote shares CRMD – CorMedix Inc. Stock Price stock today
news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRMD – CorMedix Inc. yahoo finance google finance
stock history CRMD – CorMedix Inc. invest stock market
stock prices CRMD premarket after hours
ticker CRMD fair value insiders trading